Quantel Medical creates a new subsidiary in Poland

Quantel Medical creates a new subsidiary in Poland

Quantel Medical creates a new subsidiary in Poland

Quantel Medical announces the opening of its new Polish subsidiary: Quantel Medical Polska. This company will commercialize the complete range of ultrasound, laser and dry eye diagnostics products. Quantel Medical Polska has also been appointed exclusive distributor for the products of FCI company (a Zeiss group company).

Growth of the Polish market and increasing need for ophthalmological products

With a population of 38.4 million and an average GDP growth of more than 3%, Poland is one of the top five European countries where citizens’ standard of living has considerably evolved. Poland has more than 4,500 ophthalmologists and is witnessing significant growth in demand for ophthalmological products owing to demographic change and its ageing population.

Quantel Medical – operating in the Polish market for 20 years

We have been operating in the Polish market for more 20 years and are the leading provider of ophthalmic ultrasound systems, as well as one of the top three suppliers of retinal lasers”, says Jean-Marc Gendre, CEO of Quantel Medical. Given the growth that the Polish ophthalmology market is currently experiencing, we’ve decided to set up our own subsidiary and directly address the needs of Polish ophthalmologists for diagnosis and treatment products for retinal diseases, glaucoma, AMD, cataracts and dry eye.

Quantel Medical Polska was participating at the national ophthalmology congress starting June 8th where Quantel Medical’s latest innovations were showcased. Among them, a specific focus was put on LacryDiag, the new ocular surface analyzer device for dry eye diagnosis and VITRA 2, a new generation of retinal photocoagulation laser.

The information collected through this form is recorded and transmitted to the relevant LUMIBIRD MEDICAL departments and enables us to send you any reply to a request via the contact form. The legal basis for the processing is consent. The data collected are kept for 3 years in digital format and are only transmitted to LUMIBIRD MEDICAL’s internal departments as well as to our distributors and subsidiaries. You have a right to access, rectify, contest, limit the processing of and erase data. For more information on the use of your data and your rights resulting from the amended French Data Protection Act and the GDPR, please consult our data protection policy or contact our Data Protection Officer at rgpd@lumibirdmedical.com.
For more informations on how Quantel Medical uses your data, please see our Terms and conditions.